Nalgesin S (Naproxen Sodium)

Naproxen Sodium, the active ingredient in Nalgesin S, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for systemic use. It is used to relieve mild to moderate pain, reduce inflammation in conditions such as arthritis, and lower fever in adult patients.

GNH USA supplies Nalgesin S as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nalgesin S, an NSAID, acts on inflammatory pathways to provide symptomatic relief in several common conditions.

- Mild to moderate pain: reduces pain intensity and improves functional ability. - Osteoarthritis and rheumatoid arthritis: diminishes joint inflammation and stiffness. - Fever: lowers elevated body temperature associated with acute infections or inflammatory states.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal upset: dyspepsia, nausea, or abdominal discomfort. - Headache or dizziness. - Mild skin rash or pruritus.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Renal impairment or reduced kidney function. - Cardiovascular events such as myocardial infarction or stroke. - Severe skin reactions including Stevens‑Johnson syndrome. - Hepatic dysfunction with elevated liver enzymes.

Before initiating therapy, consider patient‑specific risk factors and monitor appropriately.

- Assess gastrointestinal risk: evaluate history of ulcers or bleeding. - Monitor renal function: especially in patients with pre‑existing kidney disease. - Use the lowest effective dose for the shortest duration needed. - Avoid in individuals with known hypersensitivity to naproxen or other NSAIDs. - Take with food or an antacid to lessen stomach irritation. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Naproxen Sodium can affect the safety or efficacy of several co‑administered medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Corticosteroids: heightened ulcer risk. - Lithium: elevated lithium serum concentrations. - Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely):\n- Diuretics: possible reduction in renal perfusion. - Antihypertensives (e.g., ACE inhibitors, ARBs): may blunt blood pressure control. - Oral hypoglycemics: potential alteration of glucose levels.